Cargando…

Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial

BACKGROUND: Outcomes of extremely low gestational age neonates (ELGANs) may be adversely impacted by packed red blood cell (pRBC) transfusions. We investigated the impact of transfusions on neurodevelopmental outcome in the Preterm Erythropoietin (Epo) Neuroprotection (PENUT) Trial population. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vu, Phuong T., Ohls, Robin K., Mayock, Dennis E., German, Kendell R., Comstock, Bryan A., Heagerty, Patrick J., Juul, Sandra E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797706/ https://www.ncbi.nlm.nih.gov/pubmed/33432157 http://dx.doi.org/10.1038/s41390-020-01273-w

Ejemplares similares

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
por: Wood, Thomas R., et al.
Publicado: (2021)

Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2022)

Contemporary Definitions of Infant Growth Failure and Neurodevelopmental and Behavioral Outcomes in Extremely Premature Infants at Two Years of Age
por: Strobel, Katie, et al.
Publicado: (2023)

Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches
por: Juul, Sandra E., et al.
Publicado: (2022)

Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns
por: Valentine, Gregory, et al.
Publicado: (2023)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial
por: Juul, Sandra E., et al.
Publicado: (2023)

Patterns of Infections among Extremely Preterm Infants
por: Perez, Krystle, et al.
Publicado: (2023)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
por: Law, Janessa B., et al.
Publicado: (2021)

Commentary – Do the negative results of the PENUT trial close the book on erythropoietin for premature infant brain?
por: Volpe, Joseph J.
Publicado: (2020)

Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
por: Juul, Sandra E., et al.
Publicado: (2022)

Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates: A Secondary Analysis of the PENUT Randomized Clinical Trial
por: Starr, Michelle C., et al.
Publicado: (2023)

Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
por: Askenazi, David J., et al.
Publicado: (2022)

Whole genome methylation and transcriptome analyses to identify risk for cerebral palsy (CP) in extremely low gestational age neonates (ELGAN)
por: Massaro, An N., et al.
Publicado: (2021)

How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?
por: Wu, Yvonne W., et al.
Publicado: (2023)

Iron Supplementation and the Risk of Bronchopulmonary Dysplasia in Extremely Low Gestational Age Newborns
por: Garcia, Melissa R, et al.
Publicado: (2023)

Iron and Neurodevelopment in Preterm Infants: A Narrative Review
por: German, Kendell R., et al.
Publicado: (2021)

COVID-19 trial co-enrolment and subsequent enrolment
por: Gertner, Elie
Publicado: (2020)

INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty
por: Gray, Leigh A, et al.
Publicado: (2007)

Neurodevelopmental problems and extremes in BMI
por: Kerekes, Nóra, et al.
Publicado: (2015)

Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis
por: Staples, Margaret P, et al.
Publicado: (2011)

Prediction of clinical trial enrollment rates
por: Bieganek, Cameron, et al.
Publicado: (2022)

Real-time enrollment dashboard for multisite clinical trials
por: Mattingly, William A., et al.
Publicado: (2015)

Factors influencing the enrollment in randomized controlled trials in orthopedics
por: Lim, Christopher T., et al.
Publicado: (2017)

Twin-to-twin transfusion syndrome neurodevelopmental follow-up study (neurodevelopmental outcomes for children whose twin-to-twin transfusion syndrome was treated with placental laser photocoagulation)
por: Bolch, Christie, et al.
Publicado: (2018)

Neonatal morbidity occurs despite pulmonary maturity prior to 39 weeks gestation
por: Vanderhoeven, Jeroen P, et al.
Publicado: (2014)

Disparities in patient enrollment on glioblastoma clinical trials
por: Liu, Yang, et al.
Publicado: (2020)

Does a Split-Week Gestational Age Model Provide Valuable Information on Neurodevelopmental Outcomes in Extremely Preterm Infants?
por: Asztalos, Elizabeth, et al.
Publicado: (2021)

Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges
por: Cafferty, F.H., et al.
Publicado: (2017)

BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonates
por: Teofili, Luciana, et al.
Publicado: (2022)

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials
por: Townsley, Carol A, et al.
Publicado: (2006)

Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2022)

Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990–2000: a retrospective cohort study
por: Washburn, Lisa K, et al.
Publicado: (2007)

Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics
por: Siembida, Elizabeth J, et al.
Publicado: (2022)

Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial
por: DeVore, Adam D., et al.
Publicado: (2018)

Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
por: Glass, Hannah C., et al.
Publicado: (2023)

Phase 1 Clinical Trials in the Elderly: Enrollment Challenges
por: Guarnieri, Carol, et al.
Publicado: (2020)

Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial
por: Shah-Williams, Ebony, et al.
Publicado: (2020)

The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
por: Tariq, Syed Maaz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujn4ur97r4nrqafnps2obju6jf